These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 14742994

  • 21. Soluble interleukin-2 receptor (sIL-2R) levels in renal transplantation: comparison between clinical and laboratory analysis.
    Montagnino G, Tarantino A, Grignani S, Braga M, Ponticelli C.
    Clin Transplant; 1995 Feb; 9(1):25-30. PubMed ID: 7742579
    [Abstract] [Full Text] [Related]

  • 22. Strong inflammatory cytokine response in male and strong anti-inflammatory response in female kidney transplant recipients with urinary tract infection.
    Sadeghi M, Daniel V, Naujokat C, Wiesel M, Hergesell O, Opelz G.
    Transpl Int; 2005 Feb; 18(2):177-85. PubMed ID: 15691270
    [Abstract] [Full Text] [Related]

  • 23. A single-dose daclizumab induction protocol in renal allograft recipients: a Chinese single center experience.
    Ji SM, Li LS, Cheng Z, Cheng DR, Sun QQ, Chen JS, Sha GZ, Liu ZH.
    Transplant Proc; 2007 Jun; 39(5):1396-401. PubMed ID: 17580147
    [Abstract] [Full Text] [Related]

  • 24. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
    Panigrahi A, Deka R, Bhowmik D, Dash SC, Tiwari SC, Guleria S, Mehta SN, Mehra NK.
    Clin Transplant; 2006 Jun; 20(1):85-90. PubMed ID: 16556160
    [Abstract] [Full Text] [Related]

  • 25. Treatment of epidermolysis bullosa acquisita with the humanized anti-Tac mAb daclizumab.
    Egan CA, Brown M, White JD, Yancey KB.
    Clin Immunol; 2001 Nov; 101(2):146-51. PubMed ID: 11683573
    [Abstract] [Full Text] [Related]

  • 26. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
    Bien E, Balcerska A.
    Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
    [Abstract] [Full Text] [Related]

  • 27. One-year outcomes in simultaneous kidney-pancreas transplant recipients receiving an alternative dosing regimen of daclizumab.
    Stratta RJ, Alloway RR, Lo A, Hodge EE, PIVOT Study Group.
    Transplant Proc; 2004 May; 36(4):1080-1. PubMed ID: 15194375
    [Abstract] [Full Text] [Related]

  • 28. Subclinical inflammation in renal transplant recipients: impact of cyclosporine microemulsion versus tacrolimus.
    Lauzurica R, Pastor MC, Bayes B, Malumbres S, Homs M, Llopis MA, Bonet J, Romero R.
    Transplant Proc; 2007 Sep; 39(7):2170-2. PubMed ID: 17889127
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The weight of pharmacokinetic parameters for mycophenolic acid in prediction of rejection outcome: the receiver operating characteristic curve analysis.
    Pawinski T, Durlik M, Szlaska I, Urbanowicz A, Ostrowska J, Gralak B, Majchrzak J.
    Transplant Proc; 2006 Sep; 38(1):86-9. PubMed ID: 16504671
    [Abstract] [Full Text] [Related]

  • 31. Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial.
    Busse WW, Israel E, Nelson HS, Baker JW, Charous BL, Young DY, Vexler V, Shames RS, Daclizumab Asthma Study Group.
    Am J Respir Crit Care Med; 2008 Nov 15; 178(10):1002-8. PubMed ID: 18787222
    [Abstract] [Full Text] [Related]

  • 32. Two doses of daclizumab with delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors >55 years of age.
    Osuna A, Gentil MA, Capdevila L, Cantarell C, Mazuecos A, Pereira P, Rodríguez-Algarra G, González-Molina M, Spanish Kidney Transplant of Elderly Donor Study Group.
    Transplant Proc; 2005 Apr 15; 37(3):1438-40. PubMed ID: 15866630
    [Abstract] [Full Text] [Related]

  • 33. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
    Sundberg AK, Rohr MS, Hartmann EL, Adams PL, Stratta RJ.
    Clin Transplant; 2004 Apr 15; 18 Suppl 12():61-6. PubMed ID: 15217410
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Maternal serum levels of interferon-gamma and interleukin-2 soluble receptor-alpha predict the outcome of early IVF pregnancies.
    Fasouliotis SJ, Spandorfer SD, Witkin SS, Schattman G, Liu HC, Roberts JE, Rosenwaks Z.
    Hum Reprod; 2004 Jun 15; 19(6):1357-63. PubMed ID: 15105393
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.